{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T17:56:27Z","timestamp":1791568587227,"version":"4.3.4"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T00:00:00Z","timestamp":1694563200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T00:00:00Z","timestamp":1694563200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ital J Pediatr"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>We investigated changes in microR-29c and microR-146a expression in the serum of children with <jats:italic>Mycoplasma pneumoniae<\/jats:italic> pneumonia, analysed their relationship with inflammatory factors and disease severity, and evaluated their diagnostic significance.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Fifty-six children with <jats:italic>Mycoplasma pneumoniae<\/jats:italic> pneumonia were enrolled as the <jats:italic>Mycoplasma pneumoniae<\/jats:italic> pneumonia group; 37 healthy children were enrolled as the control group. The microR-29c or microR-146a serum expression levels were determined using real-time quantitative reverse transcription polymerase chain reaction. Interleukin-17, tumour necrosis factor-alpha, and interleukin-1 beta levels were detected using enzyme-linked immunosorbent assay. The correlation between serum microR-29c or microR-146a expression and inflammatory factors was analysed using the Pearson\u2019s method. Receiver operating characteristic curves were used to evaluate the diagnostic value of serum microR-29c, microR-146a, and their combined detection in <jats:italic>Mycoplasma pneumoniae<\/jats:italic> pneumonia.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Compared with that in healthy children, the microR-29c and microR-146a serum levels were significantly downregulated in children with <jats:italic>Mycoplasma pneumoniae<\/jats:italic> pneumonia; the decrease was more obvious in children with severe cases than that in those with mild cases. In addition, microR-29c and microR-146a were negatively correlated with increased expression of interleukin-17, tumour necrosis factor-alpha, and interleukin-1 beta. Receiver operating characteristic curves showed that a combination of microR-29c and microR-146a was highly suitable for diagnosing <jats:italic>Mycoplasma pneumoniae<\/jats:italic> pneumonia.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Serum microR-29c and microR-146a were underexpressed in children with <jats:italic>Mycoplasma pneumoniae<\/jats:italic> pneumonia, and diagnostic accuracy was significantly improved with combined microR-29c and microR-146a detection. Therefore, both microR-29c and microR-146a levels can be used as biomarkers for the diagnosis of <jats:italic>Mycoplasma pneumoniae<\/jats:italic> pneumonia.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13052-023-01500-0","type":"journal-article","created":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T13:01:49Z","timestamp":1694610109000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Peripheral blood microR-146a and microR-29c expression in children with Mycoplasma pneumoniae pneumonia and its clinical value"],"prefix":"10.1186","volume":"49","author":[{"given":"Jingcai","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqing","family":"Jing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,13]]},"reference":[{"issue":"4","key":"1500_CR1","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1002\/ppul.10346","volume":"36","author":"KB Waites","year":"2003","unstructured":"Waites KB. New concepts of Mycoplasma pneumoniae infections in children. Pediatr Pulmonol. 2003;36(4):267\u201378.","journal-title":"Pediatr Pulmonol"},{"issue":"5","key":"1500_CR2","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1128\/JCM.00184-16","volume":"54","author":"C Yan","year":"2016","unstructured":"Yan C, Sun H, Zhao H. Latest Surveillance data on mycoplasma pneumoniae infections in children suggesting a new epidemic occurring in Beijing. J Clin Microbiol. 2016;54(5):1400\u20131. https:\/\/doi.org\/10.1128\/JCM.00184-16. (Epub 2016 Feb 24).","journal-title":"J Clin Microbiol"},{"issue":"3","key":"1500_CR3","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.jiac.2013.09.009","volume":"20","author":"K Izumikawa","year":"2014","unstructured":"Izumikawa K, Takazono T, Kosai K, Morinaga Y, Nakamura S, Kurihara S, Imamura Y, Miyazaki T, Tsukamoto M, Yanagihara K, et al. Clinical features, risk factors and treatment of fulminant Mycoplasma pneumoniae pneumonia: a review of the Japanese literature. J Infect Chemother. 2014;20(3):181\u20135.","journal-title":"J Infect Chemother"},{"issue":"2","key":"1500_CR4","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1111\/j.1440-1843.2006.01036.x","volume":"12","author":"WC Chiang","year":"2007","unstructured":"Chiang WC, Teoh OH, Chong CY, Goh A, Tang JP, Chay OM. Epidemiology, clinical characteristics and antimicrobial resistance patterns of community-acquired pneumonia in 1702 hospitalized children in Singapore. Respirology. 2007;12(2):254\u201361.","journal-title":"Respirology"},{"issue":"1","key":"1500_CR5","doi-asserted-by":"crossref","first-page":"017","DOI":"10.1038\/s41598-017-00042-w","volume":"7","author":"M Yang","year":"2017","unstructured":"Yang M, Meng F, Wang K, Gao M, Lu R, Li M, Zhao F, Huang L, Zhang Y, Cheng G, et al. Interleukin 17A as a good predictor of the severity of Mycoplasma pneumoniae pneumonia in children. Sci Rep. 2017;7(1):017\u201313292.","journal-title":"Sci Rep"},{"issue":"9","key":"1500_CR6","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1080\/17460441.2020.1765770","volume":"15","author":"M Segal","year":"2020","unstructured":"Segal M, Slack FJ. Challenges identifying efficacious miRNA therapeutics for cancer. Expert Opin Drug Discov. 2020;15(9):987\u201392. https:\/\/doi.org\/10.1080\/17460441.2020.1765770. (Epub 2020 May 18).","journal-title":"Expert Opin Drug Discov"},{"issue":"8","key":"1500_CR7","doi-asserted-by":"publisher","first-page":"3865","DOI":"10.1093\/nar\/gkw116","volume":"44","author":"N Ludwig","year":"2016","unstructured":"Ludwig N, Leidinger P, Becker K, Backes C, Fehlmann T, Pallasch C, Rheinheimer S, Meder B, St\u00e4hler C, Meese E, et al. Distribution of miRNA expression across human tissues. Nucleic Acids Res. 2016;44(8):3865\u201377.","journal-title":"Nucleic Acids Res"},{"issue":"20","key":"1500_CR8","doi-asserted-by":"publisher","first-page":"3547","DOI":"10.1093\/bioinformatics\/bty343","volume":"34","author":"Y Yang","year":"2018","unstructured":"Yang Y, Fu X, Qu W, Xiao Y, Shen HB. MiRGOFS: a GO-based functional similarity measurement for miRNAs, with applications to the prediction of miRNA subcellular localization and miRNA-disease association. Bioinformatics. 2018;34(20):3547\u201356.","journal-title":"Bioinformatics"},{"issue":"5","key":"1500_CR9","doi-asserted-by":"publisher","first-page":"138920101505140","DOI":"10.2174\/138920101505140828161335","volume":"15","author":"Y Tutar","year":"2014","unstructured":"Tutar Y. miRNA and cancer; computational and experimental approaches. Curr Pharm Biotechnol. 2014;15(5):1.3892010150514084e+23.","journal-title":"Curr Pharm Biotechnol"},{"issue":"1","key":"1500_CR10","doi-asserted-by":"publisher","first-page":"019","DOI":"10.1186\/s13052-019-0655-5","volume":"45","author":"QL Li","year":"2019","unstructured":"Li QL, Wu YY, Sun HM, Gu WJ, Zhang XX, Wang MJ, Yan YD, Hao CL, Ji W, Chen ZR. The role of miR-29c\/B7-H3\/Th17 axis in children with Mycoplasma pneumoniae pneumonia. Ital J Pediatr. 2019;45(1):019\u20130655.","journal-title":"Ital J Pediatr"},{"issue":"Pt 6","key":"1500_CR11","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1042\/BST0361211","volume":"36","author":"AE Williams","year":"2008","unstructured":"Williams AE, Perry MM, Moschos SA, Larner-Svensson HM, Lindsay MA. Role of miRNA-146a in the regulation of the innate immune response and cancer. Biochem Soc Trans. 2008;36(Pt 6):1211\u20135.","journal-title":"Biochem Soc Trans"},{"issue":"2","key":"1500_CR12","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.neulet.2011.05.044","volume":"499","author":"YY Li","year":"2011","unstructured":"Li YY, Cui JG, Dua P, Pogue AI, Bhattacharjee S, Lukiw WJ. Differential expression of miRNA-146a-regulated inflammatory genes in human primary neural, astroglial and microglial cells. Neurosci Lett. 2011;499(2):109\u201313.","journal-title":"Neurosci Lett"},{"issue":"6","key":"1500_CR13","first-page":"2003","volume":"44","author":"HN Li","year":"2019","unstructured":"Li HN, Zhao X, Zha YJ, Du F, Liu J, Sun L. miR-146a-5p suppresses ATP-binding cassette subfamily G member 1 dysregulation in patients with refractory Mycoplasma pneumoniae via interleukin 1 receptor-associated kinase 1 downregulation. Int J Mol Med. 2019;44(6):2003\u201314.","journal-title":"Int J Mol Med"},{"issue":"153169","key":"1500_CR14","first-page":"16","volume":"68","author":"LJ Xu","year":"2020","unstructured":"Xu LJ, Chen RC, Ma XY, Zhu Y, Sun GB, Sun XB. Scutellarin protects against myocardial ischemia-reperfusion injury by suppressing NLRP3 inflammasome activation. Phytomedicine. 2020;68(153169):16.","journal-title":"Phytomedicine"},{"issue":"1","key":"1500_CR15","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1080\/14787210.2018.1414599","volume":"16","author":"H Lee","year":"2018","unstructured":"Lee H, Yun KW, Lee HJ, Choi EH. Antimicrobial therapy of macrolide-resistant Mycoplasma pneumoniae pneumonia in children. Expert Rev Anti Infect Ther. 2018;16(1):23\u201334.","journal-title":"Expert Rev Anti Infect Ther"},{"key":"1500_CR16","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.cca.2020.01.004","volume":"503","author":"L Wu","year":"2020","unstructured":"Wu L, Ye M, Qin X, Liu Y, Lv Z, Zheng R. Diagnostic value of quantitative MP-IgG for Mycoplasma pneumoniae pneumonia in adults. Clin Chim Acta. 2020;503:76\u201383.","journal-title":"Clin Chim Acta"},{"issue":"4","key":"1500_CR17","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1242\/dmm.047662","volume":"14","author":"M Hill","year":"2021","unstructured":"Hill M, Tran N. miRNA interplay: mechanisms and consequences in cancer. Dis Model Mech. 2021;14(4):15.","journal-title":"Dis Model Mech"},{"key":"1500_CR18","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.semcancer.2021.05.004","volume":"76","author":"AP Ferragut Cardoso","year":"2021","unstructured":"Ferragut Cardoso AP, Banerjee M, Nail AN, Lykoudi A, States JC. miRNA dysregulation is an emerging modulator of genomic instability. Semin Cancer Biol. 2021;76:120\u201331.","journal-title":"Semin Cancer Biol"},{"issue":"6","key":"1500_CR19","first-page":"6670","volume":"13","author":"P Wu","year":"2021","unstructured":"Wu P, Feng J, Wang W. Expression of miR-155 and miR-146a in the saliva of patients with periodontitis and its clinical value. Am J Transl Res. 2021;13(6):6670\u20137.","journal-title":"Am J Transl Res"},{"issue":"2","key":"1500_CR20","first-page":"311","volume":"43","author":"W Wu","year":"2021","unstructured":"Wu W, Xuan Y, Ge Y, Mu S, Hu C, Fan R. Plasma miR-146a and miR-365 expression and inflammatory factors in patients with osteoarthritis. Malays J Pathol. 2021;43(2):311\u20137.","journal-title":"Malays J Pathol"},{"issue":"6","key":"1500_CR21","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1111\/gtc.12764","volume":"25","author":"R Wang","year":"2020","unstructured":"Wang R, Li Q, He Y, Yang Y, Ma Q, Li C. miR-29c-3p inhibits microglial NLRP3 inflammasome activation by targeting NFAT5 in Parkinson\u2019s disease. Genes Cells. 2020;25(6):364\u201374.","journal-title":"Genes Cells"},{"issue":"1","key":"1500_CR22","doi-asserted-by":"publisher","first-page":"017","DOI":"10.1038\/s41598-017-03887-3","volume":"7","author":"X Bai","year":"2017","unstructured":"Bai X, Tang Y, Yu M, Wu L, Liu F, Ni J, Wang Z, Wang J, Fei J, Wang W, et al. Downregulation of blood serum microRNA 29 family in patients with Parkinson\u2019s disease. Sci Rep. 2017;7(1):017\u201303887.","journal-title":"Sci Rep"},{"issue":"2","key":"1500_CR23","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s10875-010-9369-6","volume":"30","author":"R Pappu","year":"2010","unstructured":"Pappu R, Ramirez-Carrozzi V, Ota N, Ouyang W, Hu Y. The IL-17 family cytokines in immunity and disease. J Clin Immunol. 2010;30(2):185\u201395.","journal-title":"J Clin Immunol"}],"container-title":["Italian Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-023-01500-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13052-023-01500-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-023-01500-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T10:23:43Z","timestamp":1700389423000},"score":1,"resource":{"primary":{"URL":"https:\/\/ijponline.biomedcentral.com\/articles\/10.1186\/s13052-023-01500-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,13]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1500"],"URL":"https:\/\/doi.org\/10.1186\/s13052-023-01500-0","relation":{},"ISSN":["1824-7288"],"issn-type":[{"value":"1824-7288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,13]]},"assertion":[{"value":"6 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was performed in accordance with the ethical standards of the responsible committee on human experimentation (Ethics Committee of Affiliated Hospital of Chengde Medical College; approval code, CYFYLL2022499) and with the Helsinki Declaration of 1975, as revised in 2008. All patients or their families were informed of the study, agreed to participate, and signed informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"119"}}